Sernova Biotherapeutics Inc (TSX:SVA)
0.1550
0.00 (0.00%)
May 25, 2026, 2:32 PM EST
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of CAD 58.44 million as of May 22, 2026. Its market cap has decreased by -11.05% in one year.
Market Cap
58.44M
Enterprise Value
62.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 17.04M to 58.44M, an increase of 242.99%. That is a compound annual growth rate of 4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 58.44M | 33.50% |
| Dec 31, 2025 | 43.77M | -40.78% |
| Dec 31, 2024 | 73.91M | -67.09% |
| Dec 29, 2023 | 224.60M | -3.01% |
| Dec 30, 2022 | 231.57M | -51.28% |
| Dec 31, 2021 | 475.26M | 238.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 74.56M |
| Sharp Therapeutics | 63.16M |
| Telescope Innovations | 63.03M |
| ME Therapeutics Holdings | 60.10M |
| NurExone Biologic | 58.91M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 37.96M |
| Defence Therapeutics | 36.00M |